Investment Analysts’ Price Target Changes for July, 1st (AIR, AKRO, ANCUF, APO, BC8, CLDX, DBK, FDX, HDD, IRBT)

Investment Analysts’ price target changes for Wednesday, July 1st:

Airbus (EPA:AIR) was given a €77.00 ($86.52) target price by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

Akero Therapeutics (NASDAQ:AKRO) had its price target raised by HC Wainwright from $33.00 to $45.00. HC Wainwright currently has a buy rating on the stock.

Alimentation Couche-Tard (OTCMKTS:ANCUF) had its price target raised by Barclays PLC from $40.00 to $47.00. The firm currently has an overweight rating on the stock.

Apollo Global Management (NYSE:APO) had its target price boosted by Barclays PLC from $44.00 to $51.00. The firm currently has an overweight rating on the stock.

Bechtle (ETR:BC8) was given a €175.00 ($196.63) target price by analysts at Warburg Research. The firm currently has a buy rating on the stock.

Celldex Therapeutics (NASDAQ:CLDX) had its target price boosted by Cantor Fitzgerald from $12.00 to $18.00. They currently have an overweight rating on the stock.

Deutsche Bank (FRA:DBK) was given a €6.50 ($7.30) target price by analysts at Kepler Capital Markets. The firm currently has a sell rating on the stock.

FedEx (NYSE:FDX) had its target price boosted by BMO Capital Markets from $130.00 to $150.00. The firm currently has a market perform rating on the stock.

FedEx (NYSE:FDX) had its price target raised by Cowen Inc from $156.00 to $167.00. Cowen Inc currently has an outperform rating on the stock.

FedEx (NYSE:FDX) had its target price increased by Goldman Sachs Group Inc from $153.00 to $169.00. The firm currently has a conviction-buy rating on the stock.

FedEx (NYSE:FDX) had its target price raised by Credit Suisse Group AG from $150.00 to $171.00. They currently have an outperform rating on the stock.

FedEx (NYSE:FDX) had its target price raised by Barclays PLC from $135.00 to $155.00. The firm currently has an equal weight rating on the stock.

FedEx (NYSE:FDX) had its price target increased by Citigroup Inc from $160.00 to $170.00. Citigroup Inc currently has a buy rating on the stock.

Heidelberger Druckmaschinen (ETR:HDD) was given a €0.85 ($0.96) price target by analysts at Warburg Research. The firm currently has a neutral rating on the stock.

iRobot (NASDAQ:IRBT) had its price target raised by Citigroup Inc from $60.00 to $85.00. The firm currently has a neutral rating on the stock.

LHC Group (NASDAQ:LHCG) had its price target boosted by Benchmark Co. from $160.00 to $190.00. The firm currently has a buy rating on the stock.

Logitech International (NASDAQ:LOGI) had its price target raised by Citigroup Inc from $60.00 to $73.00. Citigroup Inc currently has a buy rating on the stock.

Methanex (NASDAQ:MEOH) (TSE:MX) had its target price boosted by Barclays PLC from $16.00 to $18.00. They currently have an equal weight rating on the stock.

Nemetschek (ETR:NEM) was given a €60.00 ($67.42) price target by analysts at Kepler Capital Markets. The firm currently has a neutral rating on the stock.

Pacira Biosciences (NASDAQ:PCRX) had its target price increased by Royal Bank of Canada from $56.00 to $62.00. The firm currently has an outperform rating on the stock.

Renault (EPA:RNO) was given a €29.00 ($32.58) price target by analysts at Goldman Sachs Group Inc. The firm currently has a buy rating on the stock.

S&T (ETR:SANT) was given a €24.50 ($27.53) price target by analysts at Warburg Research. The firm currently has a buy rating on the stock.

Shoe Carnival (NASDAQ:SCVL) had its target price raised by Pivotal Research from $37.00 to $42.00. They currently have a buy rating on the stock.

Swiss Re (VTX:SREN) was given a CHF 91 target price by analysts at Barclays PLC. The firm currently has a buy rating on the stock.

Atlassian (NASDAQ:TEAM) had its price target raised by KeyCorp from $163.00 to $201.00. They currently have an overweight rating on the stock.

Westlake Chemical (NYSE:WLK) had its price target boosted by Barclays PLC from $47.00 to $54.00. They currently have an equal weight rating on the stock.

Zynerba Pharmaceuticals (NASDAQ:ZYNE) had its target price cut by Cantor Fitzgerald from $24.00 to $8.00. Cantor Fitzgerald currently has an overweight rating on the stock.

Receive News & Ratings for Airbus SE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Airbus SE and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply